Dewitt, NY, United States of America

Paul Siminoff

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Company. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Siminoff. Retrieved from https://idiyas.com/inventor/paul-siminoff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Paul Siminoff

Introduction

Paul Siminoff is an accomplished inventor based in Dewitt, NY (US). He has made significant contributions to the field of antiviral compounds, showcasing his expertise and innovative spirit. His work has led to the development of a unique patent that addresses important health challenges.

Latest Patents

Siminoff holds a patent for "Antiviral, substituted 1,3-dimethyl-1H-pyrazolo(3,4b)quinolines." This patent includes compounds of a specific formula where various groups are selected from a range of chemical structures. The complexity and specificity of his patent highlight his deep understanding of chemistry and its applications in medicine.

Career Highlights

Throughout his career, Siminoff has been associated with Bristol-Myers Company, a leading organization in the pharmaceutical industry. His work there has allowed him to focus on developing innovative solutions to combat viral infections. His dedication to research and development has positioned him as a valuable asset in the field.

Collaborations

Siminoff has collaborated with notable colleagues, including Ronnie R. Crenshaw and George Michael Luke. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Paul Siminoff's contributions to antiviral research and his innovative patent demonstrate his commitment to improving health outcomes. His work continues to inspire future advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…